FLU PANEL (INFLUENZA A, INFLUENZA B, H1N1, H3N2)

Flu Panel (Influenza A, Influenza B, H1N1, H3N2) is an advanced molecular diagnostic test designed to simultaneously detect multiple clinically significant influenza viruses, including Influenza A, Influenza B, H1N1, and H3N2. Using highly sensitive PCR technology, the test helps identify the specific influenza strain responsible for respiratory illness and supports timely medical management.

Influenza viruses are among the leading causes of seasonal respiratory infections worldwide. Symptoms often include fever, cough, sore throat, body aches, fatigue, headache, nasal congestion, and breathing difficulties. Early and accurate diagnosis helps guide treatment decisions, infection control measures, and patient monitoring.

Benefits of the Test

• Simultaneously detects multiple influenza virus strains.
• Provides highly sensitive and specific molecular results.
• Helps identify Influenza A, Influenza B, H1N1, and H3N2 infections.
• Supports early diagnosis and treatment planning.
• Assists in infection control and outbreak management.
• Reduces the need for multiple separate tests.
• Supports rapid clinical decision-making.
• Useful for both pediatric and adult patients.

Why Doctors Recommend This Test

Doctors recommend the Flu Panel for patients with fever, cough, sore throat, body aches, suspected influenza infection, seasonal flu outbreaks, respiratory illness, hospitalization due to viral infection, or unexplained flu-like symptoms requiring accurate pathogen identification.

The test helps identify the specific influenza virus involved and supports appropriate antiviral treatment and patient management.

Preparation Before Test

• No fasting is required.
• A nasal swab, nasopharyngeal swab, or throat swab specimen is usually collected.
• Follow all instructions provided by healthcare professionals.
• Inform your doctor about symptoms and recent illness history.
• Provide travel or exposure history when relevant.
• Early sample collection after symptom onset may improve diagnostic yield.

Normal Reporting Time

Most Flu Panel (Influenza A, Influenza B, H1N1, H3N2) reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final PCR analysis and reporting are generally completed within a few working days depending on laboratory workflow and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with influenza-like illness.
• Patients with fever and respiratory symptoms.
• Children with suspected influenza infection.
• Adults with seasonal flu symptoms.
• Hospitalized patients with respiratory disease.
• Pregnant women with suspected influenza.
• Immunocompromised individuals.
• People requiring influenza virus strain identification.

Detailed Information

Influenza viruses are highly contagious respiratory pathogens that circulate globally and cause seasonal outbreaks every year. Influenza A and Influenza B are the two major types responsible for human disease. Certain subtypes of Influenza A, including H1N1 and H3N2, have been associated with widespread outbreaks and significant public health impact.

Symptoms of influenza often overlap with other respiratory infections, making laboratory confirmation important for accurate diagnosis. Molecular testing provides direct detection of viral genetic material and offers superior sensitivity compared to many conventional diagnostic methods.

The Flu Panel uses advanced multiplex Polymerase Chain Reaction (PCR) technology to simultaneously detect and differentiate Influenza A, Influenza B, H1N1, and H3N2 from a single specimen. This comprehensive approach improves diagnostic efficiency and helps clinicians rapidly identify the causative virus.

Early diagnosis is particularly important because antiviral medications may be most effective when initiated soon after symptom onset. Rapid identification of influenza infections also helps support isolation precautions, outbreak control measures, and appropriate patient care decisions.

The test is widely used during seasonal influenza outbreaks, hospital-based surveillance programs, emergency department evaluations, and respiratory infection investigations. It is especially valuable for high-risk groups such as elderly individuals, pregnant women, young children, and patients with chronic medical conditions.

Results should always be interpreted together with clinical findings, patient history, physical examination, imaging studies, and additional laboratory investigations when necessary. Negative results do not completely exclude infection if viral levels are below the detection threshold.

At Focus Diagnostics, Flu Panel (Influenza A, Influenza B, H1N1, H3N2) testing is performed using advanced molecular diagnostic platforms, validated multiplex PCR assays, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful respiratory infection diagnostic results.